This website uses cookies to enhance the user experience.
DN

Dag Nord1959

Shareholdings
2
8
Norway Business roles
16

Roles

Management

NameRoleTotal operating incomeTotal equityShares
D
DA-NO HOLDING AS
Managing Director/CEO
-
16,593,363
60 %
directly
E
ENDOTECH AS
Managing Director/CEO
79,469,946
7,029,932
20.52 %
indirectly
E
ET INNOVASJON AS
Managing Director/CEO
-
971,452
14.46 %
indirectly
N
NEORESQ AS
Managing Director/CEO
200,000
46,542
10.58 %
indirectly

Boards

NameRoleTotal operating incomeTotal equityShares
D
DA-NO HOLDING AS
Chairman
-
16,593,363
60 %
directly
U
UTHUSSETRA 9 AS
Board Member
-
-163,964
30 %
indirectly
N
NORDIC MEDICAL GROUP AS
Chairman
-
30,854,620
21.6 %
indirectly
W
WAMALINO GROUP AS
Board Member
6,538,491
39,210,419
21.6 %
indirectly
E
ENDOTECH INVEST AS
Board Member
-
24,729
21 %
indirectly
E
ENDOTECH AS
Board Member
79,469,946
7,029,932
20.52 %
indirectly
E
ET INNOVASJON AS
Board Member
-
971,452
14.46 %
indirectly
N
NDS SECURITY AS
Board Member
25,998,338
694,428
-
B
BLAKER SAMFUNNSHUS BA
Deputy Chair
-
-
-
M
MABSEMBALLASJE AS
Chairman
13,504,197
90,000
-
B
BLAKER UNGDOMSLAG
Contact Person
-
-
-
Last update: Jul 26, 2024

Shares owned by Dag Nord

NameShare classTotal operating incomeTotal equityShare
D
DA-NO HOLDING AS
B-aksjer
Ordinære aksjer
0
0
16,593,363
16,593,363
10 %
directly 60 %
50 %
directly 60 %
U
UTHUSSETRA 9 AS
0
-163,964
30 %
indirectly
N
NORDIC MEDICAL GROUP AS
0
30,854,620
21.6 %
indirectly
W
WAMALINO GROUP AS
6,538,491
39,210,419
21.6 %
indirectly
E
ENDOTECH INVEST AS
0
24,729
21 %
indirectly
E
ENDOTECH AS
79,469,946
7,029,932
20.52 %
indirectly
E
ET INNOVASJON AS
0
971,452
14.46 %
indirectly
N
NEORESQ AS
200,000
46,542
10.58 %
indirectly
N
NIKKIMED AS
0
15,551
5.4 %
indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025